Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia

被引:160
作者
Chrétien, F
Lortholary, O
Kansau, I
Neuville, S
Gray, F
Dromer, F
机构
[1] Inst Pasteur, Unite Mycol Mol, F-75724 Paris 15, France
[2] Hop Ray Poincare, Fac Med Paris Ouest, Neuropathol Lab, Garches, France
关键词
D O I
10.1086/341564
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The pathogenesis of cerebral infection after Cryptococcus neoformans fungemia in outbred mice was investigated. Confocal microscopy and cultures on ficoll-hypaque gradient-separated blood cells were used to detect yeasts in the cytoplasms of monocytes. In semithin brain sections, poorly capsulated yeasts were seen in macrophages in the leptomeningeal space, in monocytes circulating in leptomeningeal capillaries, or in the endothelial cells themselves, strengthening the hypothesis that monocytes and endothelial cells play key roles in the pathogenesis of cryptococcal meningitis. Similar fungal loads and cellular reactions were seen in mice and in 1 patient with acquired immune deficiency syndrome (AIDS), all with acute cryptococcal meningoencephalitis, and in mice and in 1 patient with AIDS, all with cured cryptococcal infection. Immunostaining revealed both the presence of cryptococcal polysaccharide in various brain cells and antigenic variability both from yeast cell to yeast cell and over time. Thus, our data established the relevance and interest that this experimental model has for investigation of the pathogenesis of human cryptococcal meningitis.
引用
收藏
页码:522 / 530
页数:9
相关论文
共 41 条
[1]   EXPERIMENTAL-MODEL OF INTRACEREBRAL INFECTION WITH CRYPTOCOCCUS-NEOFORMANS - ROLES OF PHAGOCYTES AND OPSONIZATION [J].
BLASI, E ;
BARLUZZI, R ;
MAZZOLLA, R ;
MOSCI, P ;
BISTONI, F .
INFECTION AND IMMUNITY, 1992, 60 (09) :3682-3688
[2]   What makes Cryptococcus neoformans a pathogen? [J].
Buchanan, KL ;
Murphy, JW .
EMERGING INFECTIOUS DISEASES, 1998, 4 (01) :71-83
[3]   HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-INFECTED HUMAN BLOOD MONOCYTES AND PERITONEAL-MACROPHAGES HAVE REDUCED ANTICRYPTOCOCCAL ACTIVITY WHEREAS HIV-INFECTED ALVEOLAR MACROPHAGES RETAIN NORMAL ACTIVITY [J].
CAMERON, ML ;
GRANGER, DL ;
MATTHEWS, TJ ;
WEINBERG, JB .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (01) :60-67
[4]   Variants of a Cryptococcus neoformans strain elicit different inflammatory responses in mice [J].
Chen, LC ;
Casadevall, A .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1999, 6 (02) :266-268
[5]   INFECTIONS WITH CRYPTOCOCCUS-NEOFORMANS IN THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
CHUCK, SL ;
SANDE, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (12) :794-799
[6]   In vitro and in vivo stability a Cryptococcus neoformans glucuronoxylomannan epitope that elicits protective antibodies [J].
Cleare, W ;
Cherniak, R ;
Casadevall, A .
INFECTION AND IMMUNITY, 1999, 67 (06) :3096-3107
[7]  
CURTIS JL, 1994, LAB INVEST, V71, P113
[8]  
DIAMOND RD, 2000, MANDELL DOUGLAS BENN, V2, P2707
[9]   Leukocyte-facilitated entry of intracellular pathogens into the central nervous system [J].
Drevets, DA ;
Leenen, PJM .
MICROBES AND INFECTION, 2000, 2 (13) :1609-1618
[10]   Epidemiology of cryptococcosis in France: A 9-year survey (1985-1993) [J].
Dromer, F ;
Mathoulin, S ;
Dupont, B ;
Laporte, A ;
Chardon, H ;
Greze, H ;
Hayette, MP ;
Chabasse, D ;
Martin, M ;
Pulik, M ;
Hautefort, B ;
LePennec, MP ;
Larfouilloux, J ;
Faller, JP ;
Barale, T ;
BougesMichel, C ;
Delzanig, G ;
Couprie, B ;
Bougnoux, ME ;
Masure, O ;
Lefort, C ;
Duhamel, C ;
Bidault, C ;
Zaegel, M ;
Allard, C ;
Laurens, E ;
Dormont, J ;
Beytout, J ;
Mollo, JL ;
Boussougant, Y ;
Cordier, F ;
Bretagne, S ;
Gaillard, JP ;
Portier, H ;
Grise, G ;
Leblanc, A ;
Bouchard, I ;
Nauciel, C ;
Lebeau, B ;
Bouree, P ;
Lagarde, A ;
Vincent, J ;
DesaillyChanson, MA ;
Eloy, O ;
Grillot, ML ;
Gosset, X ;
Capbern, P ;
Darde, ML ;
Lemercier, Y ;
Piens, MA .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (01) :82-90